Five burning Qs for Isomorphic Labs after $2.1B raise for AI biotech

Demis Hassabis, Isomorphic Labs CEO (Chris Jung/NurPhoto via AP Images) May 12, 2026 11:42 AM EDT FinancingAI Five burn­ing ques­tions for Iso­mor­phic af­ter its mam­moth $2B+ raise Andrew Dunn Senior Biopharma Correspondent Iso­mor­phic Labs said Tues­day it had closed a $2.1 bil­lion Se­ries B round, ce­ment­ing its bell­wether role in us­ing AI for drug dis­cov­ery. For pri­vate­ly … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER